“…Longer follow-up was not possible as these swine become too large for MRI. Although the sample size is small compared to human efficacy trials, it is comparable to other published large animal translational studies [27, 33, 49, 50]. Our study exploited highly sensitive and reproducible endpoints such as quantitative cardiac MRI, invasive pressure-volume hemodynamics, implanted VT monitoring, and systematic histopathology to compensate for the small sample size.…”